177 related articles for article (PubMed ID: 35952800)
1. Fibrous Clays in Dermopharmaceutical and Cosmetic Applications: Traditional and Emerging Perspectives.
Cao L; Xie W; Cui H; Xiong Z; Tang Y; Zhang X; Feng Y
Int J Pharm; 2022 Sep; 625():122097. PubMed ID: 35952800
[TBL] [Abstract][Full Text] [Related]
2. Clay minerals: Properties and applications to dermocosmetic products and perspectives of natural raw materials for therapeutic purposes-A review.
Moraes JDD; Bertolino SRA; Cuffini SL; Ducart DF; Bretzke PE; Leonardi GR
Int J Pharm; 2017 Dec; 534(1-2):213-219. PubMed ID: 29038067
[TBL] [Abstract][Full Text] [Related]
3. Folk pharmaceutical formulations in western Mediterranean: identification and safety of clays used in pelotherapy.
Sánchez-Espejo R; Aguzzi C; Cerezo P; Salcedo I; López-Galindo A; Viseras C
J Ethnopharmacol; 2014 Aug; 155(1):810-4. PubMed ID: 24960182
[TBL] [Abstract][Full Text] [Related]
4. The systems containing clays and clay minerals from modified drug release: a review.
Rodrigues LA; Figueiras A; Veiga F; de Freitas RM; Nunes LC; da Silva Filho EC; da Silva Leite CM
Colloids Surf B Biointerfaces; 2013 Mar; 103():642-51. PubMed ID: 23253474
[TBL] [Abstract][Full Text] [Related]
5. Bacteriostatic and bactericidal clays: an overview.
Gomes CF; Gomes JH; da Silva EF
Environ Geochem Health; 2020 Nov; 42(11):3507-3527. PubMed ID: 32607701
[TBL] [Abstract][Full Text] [Related]
6. Toxicological evaluation of clay minerals and derived nanocomposites: a review.
Maisanaba S; Pichardo S; Puerto M; Gutiérrez-Praena D; Cameán AM; Jos A
Environ Res; 2015 Apr; 138():233-54. PubMed ID: 25732897
[TBL] [Abstract][Full Text] [Related]
7. Healing and edible clays: a review of basic concepts, benefits and risks.
Gomes CSF
Environ Geochem Health; 2018 Oct; 40(5):1739-1765. PubMed ID: 28150053
[TBL] [Abstract][Full Text] [Related]
8. Assessment of Clayey Peloid Formulations Prior to Clinical Use in Equine Rehabilitation.
Bastos CM; Rocha F; Cerqueira Â; Terroso D; Sequeira C; Tilley P
Int J Environ Res Public Health; 2020 May; 17(10):. PubMed ID: 32408650
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory, anti-bacterial, and cytotoxic activity of fibrous clays.
Cervini-Silva J; Nieto-Camacho A; Ramírez-Apan MT; Gómez-Vidales V; Palacios E; Montoya A; Ronquillo de Jesús E
Colloids Surf B Biointerfaces; 2015 May; 129():1-6. PubMed ID: 25819359
[TBL] [Abstract][Full Text] [Related]
10. Natural and ion-exchanged illite clays reduce bacterial burden and inflammation in cutaneous meticillin-resistant Staphylococcus aureus infections in mice.
Otto CC; Kilbourne J; Haydel SE
J Med Microbiol; 2016 Jan; 65(1):19-27. PubMed ID: 26508716
[TBL] [Abstract][Full Text] [Related]
11. Plant-mediated green synthesis of metal-based nanoparticles for dermopharmaceutical and cosmetic applications.
Paiva-Santos AC; Herdade AM; Guerra C; Peixoto D; Pereira-Silva M; Zeinali M; Mascarenhas-Melo F; Paranhos A; Veiga F
Int J Pharm; 2021 Mar; 597():120311. PubMed ID: 33539998
[TBL] [Abstract][Full Text] [Related]
12. Natural peloids originating from subsea depths of 200 m in the hupo basin, South Korea: physicochemical properties for potential pelotherapy applications.
Park C; Kim JH; Choi W; Kim D; No SG; Chung D; Lee HI; Seo S; Seo SM
Environ Geochem Health; 2024 Jun; 46(7):240. PubMed ID: 38849660
[TBL] [Abstract][Full Text] [Related]
13. Fibrous palygorskite clays as versatile nanocarriers for skin delivery of tea tree oils in efficient acne therapy.
Zhang Z; Zhang X; Fu Z; Cao L; Xiong Z; Tang Y; Feng Y
Int J Pharm; 2022 Jul; 623():121903. PubMed ID: 35697203
[TBL] [Abstract][Full Text] [Related]
14. One-dimensional filtration of pharmaceutical grade phyllosilicate dispersions.
Viseras C; Cerezo P; Meeten GH; Lopez-Galindo A
Int J Pharm; 2001 Apr; 217(1-2):201-13. PubMed ID: 11292556
[TBL] [Abstract][Full Text] [Related]
15. Microalgal Peloids for Cosmetic and Wellness Uses.
Mourelle ML; Gómez CP; Legido JL
Mar Drugs; 2021 Nov; 19(12):. PubMed ID: 34940665
[TBL] [Abstract][Full Text] [Related]
16. Influence of clay mineral structure and surfactant nature on the adsorption capacity of surfactants by clays.
Sánchez-Martín MJ; Dorado MC; del Hoyo C; Rodríguez-Cruz MS
J Hazard Mater; 2008 Jan; 150(1):115-23. PubMed ID: 17532126
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress inhibition and oxidant activity by fibrous clays.
Cervini-Silva J; Nieto-Camacho A; Gómez-Vidales V
Colloids Surf B Biointerfaces; 2015 Sep; 133():32-5. PubMed ID: 26071933
[TBL] [Abstract][Full Text] [Related]
18. Pharmaceutical grade phyllosilicate dispersions: the influence of shear history on floc structure.
Viseras C; Meeten GH; Lopez-Galindo A
Int J Pharm; 1999 May; 182(1):7-20. PubMed ID: 10332070
[TBL] [Abstract][Full Text] [Related]
19. Polyacrylate crosspolymer-11 enhances soil clay dispersibility: An indication for inadvertent environmental impacts from personal care and cosmetic ingredients.
Nguyen LN; Nguyen AM; Nguyen MT; Dinh VM; Mai NT; Nguyen MN
Sci Total Environ; 2022 Feb; 806(Pt 1):150459. PubMed ID: 34571229
[TBL] [Abstract][Full Text] [Related]
20. Crude oil polycyclic aromatic hydrocarbons removal via clay-microbe-oil interactions: Effect of acid activated clay minerals.
Ugochukwu UC; Fialips CI
Chemosphere; 2017 Jul; 178():65-72. PubMed ID: 28319743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
